Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

PRPH

ProPhase Labs Inc

Dec 05 • 04:00PM ET

0.1300

-0.0100 -7.14 %

Healthcare • Diagnostics & Research • USA • NASD

Dec 02, 3:02 PMLingering fallout from Q3 earnings disclosures triggered a sharp intraday selloff amid liquidity fears.

Peers: JNJ PFE MRNA BMY GILD ABBV LLY VRTX REGN VTRS

| Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.50	Insider Own	7.99%	Shs Outstand	46.18M	Perf Week	-37.77%
Market Cap	6.00M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	42.49M	Perf Month	-56.39%
Enterprise Value	13.27M	PEG	-	EPS next Q	-	Inst Own	6.56%	Short Float	0.21%	Perf Quarter	-65.80%
Income	-27.76M	P/S	0.47	EPS this Y	-	Inst Trans	1.46%	Short Ratio	0.03	Perf Half Y	-63.69%
Sales	12.75M	P/B	0.79	EPS next Y	-	ROA	-30.25%	Short Interest	0.09M	Perf YTD	-82.83%
Book/sh	0.17	P/C	14.63	EPS next 5Y	-	ROE	-58.71%	52W High	0.93 -86.09%	Perf Year	-83.25%
Cash/sh	0.01	P/FCF	-	EPS past 3/5Y	- -57.56%	ROIC	-354.66%	52W Low	0.12 6.12%	Perf 3Y	-98.75%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-55.92% -7.27%	Gross Margin	-32.38%	Volatility	19.31% 15.96%	Perf 5Y	-98.59%
Dividend TTM	-	EV/Sales	1.04	EPS Y/Y TTM	-141.87%	Oper. Margin	-277.69%	ATR (14)	0.04	Perf 10Y	-84.61%
Dividend Ex-Date	May 24, 2022	Quick Ratio	0.14	Sales Y/Y TTM	-79.66%	Profit Margin	-217.64%	RSI (14)	25.01	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.14	EPS Q/Q	49.48%	SMA20	-38.97%	Beta	-0.62	Target Price	16.00
Payout	-	Debt/Eq	1.12	Sales Q/Q	-64.31%	SMA50	-63.32%	Rel Volume	1.13	Prev Close	0.14
Employees	96	LT Debt/Eq	0.14	Earnings	Nov 19 BMO	SMA200	-64.58%	Avg Volume	2.61M	Price	0.13
IPO	Apr 22, 1997	Option/Short	Yes / Yes	EPS/Sales Surpr.	- -	Trades		Volume	2,940,241	Change	-7.14%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-20-21	Initiated	H.C. Wainwright	Buy	$12
Oct-13-21	Downgrade	Dawson James	Buy → Neutral
Jan-20-21	Initiated	Dawson James	Buy	$25

Nov-26-25 08:01PM	ProPhase Labs Inc (PRPH) Q3 2025 Earnings Call Highlights: Strategic Initiatives and Financial ... (GuruFocus.com) +15.41%
08:00AM	Join ProPhase Labs' Exclusive Live Investor Webinar and Q&A Session on December 1 (GlobeNewswire)
Nov-19-25 08:13AM	ProPhase Labs Reported Results for the Third Quarter Ended September 30, 2025, and Will Hold a Virtual Conference Call Today at 2pm ET. (GlobeNewswire) -9.53%
Nov-18-25 08:00AM	ProPhase Labs, Inc. to Present Third Quarter 2025 Financial Results on November 19 (GlobeNewswire)
Nov-17-25 08:00AM	ProPhase Labs Urges Shareholders to Vote by November 23 on Proxy Proposals (GlobeNewswire) -5.39%
08:30AM	Loading…
Oct-29-25 08:30AM	ProPhase Labs Announces Publication of BE-Smart Esophageal Cancer Study in the Official Journal of the American College of Gastroenterology (GlobeNewswire)
Oct-28-25 08:00AM	ProPhase Labs Engages RedChip Companies to Lead Investor Relations Efforts (GlobeNewswire)
Oct-24-25 08:00AM	ProPhase Labs to Present at the 2025 ThinkEquity Conference (GlobeNewswire) +10.41%
Oct-22-25 07:30AM	ProPhase Labs Announces Study Validating BE-Smart Esophageal Cancer Test Accepted by Journal of Clinical Gastroenterology and Hepatology (GlobeNewswire) -20.53%
Sep-23-25 01:41PM	Critical Biotech giant files Chapter 11 for 3 COVID labs, eyes Bitcoin treasury as lifeline (TheStreet)
01:41PM	Biotech firm files Chapter 11 bankruptcy for 3 labs, explores crypto plan (TheStreet)
08:00AM	PROPHASE LABS, INC. ANNOUNCES COMPLETION OF IMPORTANT NEXT STEP FOR CROWN MEDICAL COLLECTIONS $50 MILLION A/R INITIATIVE (GlobeNewswire)
Sep-22-25 08:00AM	ProPhase Continues its Exploration of a Crypto Treasury Strategy (GlobeNewswire) +16.07%
Sep-12-25 08:00AM	ProPhase Labs Stockholders Approve All Proposals at September 9, 2025 Special Meeting By More Than 75% In Favor (GlobeNewswire) -15.84%
Sep-03-25 08:00AM	ProPhase Labs Inc. to Participate in Renmark's Virtual Non-Deal Roadshow Series on Thursday, September 4, 2025 (GlobeNewswire) +8.69%
08:00AM	Loading…
Aug-19-25 08:00AM	ProPhase Labs Announces Filing of Definitive Proxy Statement and New Date for Special Meeting of Shareholders (GlobeNewswire) -6.44%
Aug-15-25 01:00PM	ProPhase Labs Inc (PRPH) Q2 2025 Earnings Call Highlights: Strategic Moves and Future Prospects (GuruFocus.com) +5.05%
Aug-14-25 12:30PM	Biotech Stocks Rally as Oncology Market Targets $866B by 2034 (PR Newswire)
Aug-13-25 10:30AM	BC-Most Active Stocks (Associated Press Finance) -7.51%
08:00AM	ProPhase Labs Announces Financial Results for the Three and Six Months Ended June 30, 2025 (GlobeNewswire)
Aug-12-25 05:15PM	Journey Medical Corporation (DERM) Reports Q2 Loss, Beats Revenue Estimates (Zacks) +25.67%
10:30AM	BC-Most Active Stocks (Associated Press Finance)
08:00AM	ProPhase Labs Announces Full USPTO Approval for Issuance of U.S. Patent Protecting Esophageal Adenocarcinoma Risk Assessment (GlobeNewswire)
Aug-11-25 08:00AM	ProPhase Labs Inc. to Present Second Quarter 2025 Financial Results on August 13, 2025 (GlobeNewswire) -9.77%
Aug-07-25 08:25AM	Ironwood Pharmaceuticals (IRWD) Beats Q2 Earnings and Revenue Estimates (Zacks)
Aug-05-25 08:10AM	Zoetis (ZTS) Q2 Earnings and Revenues Surpass Estimates (Zacks)
Jul-29-25 08:00AM	ProPhase Labs Announces Special Meeting of Shareholders and Filing of Preliminary Proxy Statement (GlobeNewswire) -21.10%
Jul-23-25 08:00AM	ProPhase Labs Announces Closing of $3 Million Senior Secured Convertible Notes Financing (GlobeNewswire) +11.42%
Jul-21-25 08:00AM	ProPhase Labs Board of Directors Authorizes Management to Explore Strategic Reverse Merger and Approves Crypto Treasury Initiative (GlobeNewswire) +10.29%
Jun-26-25 07:30AM	ProPhase Labs, Inc. Receives Additional 180 Day Extension from Nasdaq to Regain Compliance with Minimum Bid Price Rule (GlobeNewswire)
11:19AM	Loading…
Jun-18-25 11:19AM	Cancer Rates Are Surging in Young Adults -- Here's Where the Smart Money Is Going (PR Newswire)
Jun-17-25 07:30AM	ProPhase Labs Announces Successful Study Demonstrating Performance of BE-Smart Test in Detecting Esophageal Cancer (GlobeNewswire) +5.23%
Jun-06-25 07:00AM	ProPhase Labs Announces Formation of Clinical Science Advisory Board to Accelerate Commercialization of BE-SmartTM Esophageal Disease Diagnostic Platform (GlobeNewswire)
May-21-25 05:00PM	ProPhase Labs Inc (PRPH) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial Challenges (GuruFocus.com) -12.42% +6.97%
May-20-25 08:00AM	ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2025 (GlobeNewswire)
May-15-25 06:00PM	Vivos Therapeutics, Inc. (VVOS) Reports Q1 Loss, Lags Revenue Estimates (Zacks) +7.28%
May-14-25 08:15AM	ARS Pharmaceuticals, Inc. (SPRY) Reports Q1 Loss, Lags Revenue Estimates (Zacks) +8.24%
May-13-25 08:00AM	ProPhase Labs Inc. to Present First Quarter 2025 Financial Results on May 20, 2025 (GlobeNewswire)
May-07-25 06:45PM	Inotiv, Inc. (NOTV) Reports Q2 Loss, Tops Revenue Estimates (Zacks) +5.73% +6.29%
May-05-25 08:20AM	BioCryst Pharmaceuticals (BCRX) Reports Break-Even Earnings for Q1 (Zacks) -10.92%
Apr-03-25 09:00AM	ProPhase Labs Inc (PRPH) Q4 2024 Earnings Call Highlights: Strategic Moves and Financial Challenges (GuruFocus.com) -11.28%
Mar-31-25 09:08PM	ProPhase Labs, Inc. (PRPH) Q4 2024 Earnings Call Transcript (Seeking Alpha) -8.11%
08:00AM	ProPhase Labs, Inc. Announces Financial Results for the Year Ended December 31, 2024 (GlobeNewswire)
Mar-27-25 08:27AM	ProPhase Labs Inc. to Present 2024 Year End Financial Results on March 31, 2025 (GlobeNewswire)
Mar-26-25 05:20PM	Durect (DRRX) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
Mar-18-25 03:30PM	Q1 Virtual Investor Summit: On-Demand Presentations Now Live (ACCESS Newswire)
Mar-07-25 08:00AM	ProPhase Labs to Present at the Investor Summit Virtual on March 11 (GlobeNewswire)
Mar-05-25 09:55AM	Bears are Losing Control Over ProPhase Labs (PRPH), Here's Why It's a 'Buy' Now (Zacks) +8.27%
Feb-26-25 08:00AM	Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH) (GlobeNewswire) -9.82%
Feb-25-25 08:00AM	ProPhase Labs Examines Strategic Opportunities to Leverage Its DTC Multi-Media Infrastructure with Telehealth Physician Networks for Prescription Drugs (GlobeNewswire) -8.63%
Feb-20-25 08:00AM	ProPhase Labs Announces Excellent Progress with Crown Medical Collections Targeting Over $50 Million in Net Near-Term Cash Recovery from COVID-19 Receivables (GlobeNewswire)
Feb-18-25 08:00AM	ProPhase Labs hires Stuart Hollenshead as COO, the former COO and CBO of Barstool Sports (GlobeNewswire) +35.08%
Jan-22-25 08:00AM	ProPhase Labs Announces Closing of $23.6 Million Sale of Pharmaloz Manufacturing to Houston-Based Private Equity Firm (GlobeNewswire) -16.08%
Dec-11-24 08:00AM	ProPhase Labs Secures Global Private Equity Backing, Nears Major Lozenge Deal, Adds Seasoned Industry Expert, and Plans Significant Cost-Cutting Measures (GlobeNewswire)
Nov-19-24 08:00AM	Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision (GlobeNewswire)
Nov-18-24 08:01PM	ProPhase Labs Inc (PRPH) Q3 2024 Earnings Call Highlights: Strategic Launches and Financial ... (GuruFocus.com)
08:00AM	Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH) (GlobeNewswire)
Nov-13-24 09:15AM	ProPhase Labs, Inc. (PRPH) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
08:00AM	ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2024 (GlobeNewswire)
Nov-12-24 04:05PM	ProPhase Labs Announces Closing of Public Offering of Common Stock (GlobeNewswire)
Nov-11-24 09:52AM	ProPhase Labs Inc. to Present Third Quarter 2024 Financial Results on November 13, 2024 (GlobeNewswire) -5.26%
Nov-07-24 11:37PM	ProPhase Labs Announces Pricing of Public Offering of Common Stock (GlobeNewswire) -26.29% -45.45%
04:05PM	ProPhase Labs Announces Proposed Public Offering of Common Stock (GlobeNewswire)
Nov-04-24 08:00AM	ProPhase Labs Launches DNA Complete : Transforming Direct-to-Consumer Genetic Testing for Health, Wellness, and Enhanced Ancestry (GlobeNewswire)
Oct-22-24 08:00AM	ProPhase Labs to Present at the 2024 ThinkEquity Conference (GlobeNewswire)
Oct-17-24 08:00AM	ProPhase Labs Announces Positive Updates on Strategic Initiatives Company Anticipates Multiple Liquidity Events in H1 2025 (GlobeNewswire)
Sep-11-24 01:00PM	Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing (ACCESSWIRE)
Aug-27-24 08:00AM	Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH) (GlobeNewswire)
Aug-22-24 08:00AM	Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH) (GlobeNewswire)
Aug-19-24 11:10AM	ProPhase Labs to Present at August 20th Virtual Investor Summit Microcap Event (GlobeNewswire) +17.60%
Aug-14-24 08:00AM	ProPhase Labs Announces Financial Results for the Three Months Ended June 30, 2024 (GlobeNewswire)
Aug-13-24 08:00AM	ProPhase Labs Announces Collaboration with Forward Healthcare Consultants to Aid in the Commercialization of its Billion Dollar Potential BE-Smart Esophageal Cancer Test (GlobeNewswire) -6.79%
Aug-07-24 08:00AM	PROPHASE LABS INC. TO PRESENT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 14 (GlobeNewswire) -5.49%
Jul-11-24 08:00AM	ProPhase Labs Announces Update on Pharmaloz Manufacturing, Inc. Progress (GlobeNewswire)
May-16-24 08:00AM	Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH) (GlobeNewswire)
May-10-24 04:19PM	ProPhase Labs, Inc. (NASDAQ:PRPH) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-09-24 03:40PM	ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives. - Updated (GlobeNewswire) -8.72%
08:00AM	ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives. (GlobeNewswire)
May-02-24 10:01AM	ProPhase Labs, Inc. (PRPH) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
08:00AM	PROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9 (GlobeNewswire)
Apr-29-24 09:00AM	Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV (ACCESSWIRE)
Apr-25-24 08:00AM	ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024 (GlobeNewswire)
Apr-23-24 09:00AM	Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH) (GlobeNewswire) +5.31%
Apr-16-24 08:00AM	ProPhase Labs Unveils Project ZenQ-AI (GlobeNewswire) +19.42%
Apr-10-24 08:00AM	ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024 (GlobeNewswire)
Apr-01-24 09:00PM	ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +5.87%
Mar-18-24 09:20AM	ProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2023 Earnings Call Transcript (Insider Monkey)
09:08AM	Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH) (GlobeNewswire)
Mar-15-24 12:53PM	PRPH Stock Earnings: ProPhase Labs Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace)
08:00AM	ProPhase Labs Announces Financial Results for the Year Ended December 31, 2023 and Significant Progress in Its Strategic Initiatives (GlobeNewswire)
Mar-08-24 08:00AM	PROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 2024 (GlobeNewswire)
Feb-21-24 08:00AM	Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH) (GlobeNewswire)
Feb-20-24 08:00AM	ProPhase Labs Announces Significant Progress in BE-Smart Esophageal Cancer Test Development USPTO grants additional broad patents for BE-SMART (GlobeNewswire)
Feb-14-24 08:00AM	ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement Equivir (GlobeNewswire)
Feb-08-24 08:00AM	Diamond Equity Research Releases In Depth Update Note on ProPhase Labs, Inc. (NASDAQ: PRPH) subsidiary, Pharmaloz Manufacturing, Inc. (PMI) (GlobeNewswire)
Jan-30-24 08:00AM	ProPhase Labs Ushers in New Genomics Era with Jason Karkus at the Helm of Nebula Genomics (GlobeNewswire)
Jan-23-24 08:00AM	Pharmaloz Manufacturing Accelerates Expansion, Improves Pricing, Boosts Profitability and Secures New Contracts (GlobeNewswire)
Jan-04-24 08:00AM	ProPhase poised to ramp up growth at Pharmaloz and Nebula Genomics in 2024 (GlobeNewswire)
Nov-10-23 01:50PM	ProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2023 Earnings Call Transcript (Insider Monkey) -10.78%
Nov-09-23 09:25AM	ProPhase Labs Inc (PRPH) Reports Mixed Q3 Results Amid Strategic Transformations (GuruFocus.com) +7.82%

ProPhase Labs, Inc. is a medical science and technology company, which engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer healthcare products and dietary supplements. It operates through the Diagnostic Services and Consumer Products segment. The Diagnostic Services segment includes COVID-19 and other diagnostic testing services. The Consumer Products segment consists of the manufacturing, retail customers, and personal genomics products and services. The company was founded by Guy J. Quigley and Charles A. Phillips in July 1989 and is headquartered in Garden City, NY.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PRPH

ProPhase Labs Inc

Upgrade your FINVIZ experience